Stockreport

Rani Therapeutics GAAP EPS of -$0.24 in-line [Seeking Alpha]

Rani Therapeutics Holdings, Inc. - Class A  (RANI) 
PDF Net loss for the three months ended September 30, 2024 was $12.7 million. More on Rani Therapeutics Rani Therapeutics to sell 3M shares at $3.00 in registered direc [Read more]